Alnylam announces positive interim analysis results from ENVISION phase III study of givosiran Sep. 28, 2018
Positive data reported from phase Ib PK study of zilucoplan in patients with renal impairment Sep. 28, 2018
Preclinical characterization and evaluation of the bacterial ribosome inhibitor NOSO-502 Sep. 28, 2018
Malaria transmission-blocking vaccine Pf25H-EPA/Alhydrogel does not prevent reinfection Sep. 28, 2018
RSS